Your browser doesn't support javascript.
loading
Analyze The Treatment Regimens And Thrombosis Prophylaxis Used In Coronary Artery Intervention At Interventional Cardiology Unit In Can Tho Central General Hospital
Int J Pharm Pharm Sci ; 2019 Dec; 11(12): 1-4
Article | IMSEAR | ID: sea-205976
ABSTRACT

Objective:

The study was conducted to analyze the rationality of treatment regimens and thrombosis prophylaxis used in coronary artery intervention to compare to guidelines for treatment according to VNHA and recommendation of ACC/AHA at Interventional cardiology in Can Tho Central General Hospital.

Methods:

The cross-sectional study was based on the data collected from entire medical records of patients at Interventional cardiology in Can Tho Central General Hospital from August 2017 to February 2018. The rationality of the antithrombotic regimen used at the Hospital is assessed through criteria such as medical combination, dosage, time to take medicine, clinical trials during the treatment.

Results:

The study found that 95.6% and 90.7% were suitable for medical combination before and after PCI; 100% fit for the use of medicine; and 100% was suitable for antithrombotic agents and clinical trials during treatment time; in terms of dosage, the result showed that entrance and maintenance were 84.9% and 100% for aspirin respectively; 71.7% and 100% for clopidogrel; 100% and 94.7% for ticagrelor; 90.2-92.8% and 98.1% for enoxaparin; especially, heparin-100% anticoagulant was appropriate to recommend.

Conclusion:

The study showed that treatment regimens and thrombosis prophylaxis in percutaneous coronary intervention at Interventional cardiology in Can Tho Central General Hospital were quite suitable compared to the recommendations of the Heart Association. The results from the study are a scientific basis for the Hospital to maintain or consider adjustments to improve the quality of treatment, ensure the effectiveness and safety of patients.

Full text: Available Index: IMSEAR (South-East Asia) Type of study: Practice guideline / Observational study / Risk factors Journal: Int J Pharm Pharm Sci Year: 2019 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: IMSEAR (South-East Asia) Type of study: Practice guideline / Observational study / Risk factors Journal: Int J Pharm Pharm Sci Year: 2019 Type: Article